DataM Intelligence | competitive Intelligence CIDP treatment evolves with novel approvals like Vyvgart Hytrulo and HYQVIA, offering patient ...

Ten years after the original BMW M2 debuted, the Bavarian automaker has introduced a model that wears similar badging but ...

HP, rear-wheel drive, and track-honed precision. Discover its S58 twin-turbo engine, carbon fiber upgrades, and why it’s a ...

Indiana coach Rick Carlisle is a product of upstate New York. His hometown didn't even have a way for him to watch NBA games ...

CSL to benefit from strong reroofing demand and strategic acquisitions, but the CWT segment and rising costs weigh on growth. Generating cash is essential for any business, but not all cash-rich ...

The collaborative entered into an agreement to purchase the roughly 27-acre property in the eastern portion of Carlisle in ...

CSL and uniQure’s gene therapy for haemophilia B has been approved by the European Commission, ushering in a new era of therapy for patients with the bleeding disorder in the EU. The therapy has ...

CSL Behring's recently approved gene therapy for haemophilia B Hemgenix has joined the swelling ranks of new medicines that are bundled with a companion app to support the patients treated with them.

Home improvement costs can vary depending on what part of the home you're fixing, but according to Rocket Mortgage, Americans spent an average of $22,000 on a single home improvement project in 2023.

NatWest Group PLC, Pernod Ricard SA, Novo Nordisk A/S Class B, Software AG. Read 's Market Analysis on Investing.com UK.